Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Recipharm has announced the appointment of a new business director for the Italian pharmaceutical market and a new General Manager at Pessac, France.
read more
Wednesday, February 27, 2019
PredictImmune confirmed its latest patent grant in the US. The US patent is part of PredictImmune’s third family of IP relating to methods for predicting autoimmune disease risk.
read more
nanoComposix recently received its Drug Manufacturing License from the Food and Drug Branch of the State of California Department of Public Health.
read more
Monday, December 30, 2019
Cyclo Therapeutics has signed a Master Services Agreement with Worldwide Clinical Trials to serve as CRO for the Company’s clinical programs evaluating Trappsol Cyclo.
read more
Tuesday, October 31, 2017
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their partnership to develop novel immuno-oncology therapies
read more
Wednesday, December 27, 2017
MilliporeSigma announced a collaboration with IPS-Integrated Project Services and G-CON to provide 2,000L MAb facility and single-use process technology platform.
read more
Thursday, December 01, 2022
Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) specializing in lentiviral and retroviral vector manufacturing, continues to scale and expand its commercial operations with the appointment of Jeff Whitmore ...
read more
The company is now supporting more than 200 of these projects globally.
read more
Southern Research has been awarded a seven-year contract of up to $22 million to support research that could contribute to the cure of HIV disease. Under this contract, Southern Research will develop and standardize assays that quantitate latent ...
read more
Marken has expanded their network of qualified third party service providers and customs brokers to reinforce the company's infrastructure and prepare for a significant increase in drug, vaccine, API and ancillary shipment volume.
read more
Wednesday, September 14, 2016
Catalent has announced an agreement for Catalent, through its wholly owned subsidiary, Catalent Pharma Solutions, Inc., to acquire Pharmatek Laboratories, Inc., a West Coast, U.S.-based specialist in drug development and clinical manufacturing.
read more
Cambrex announced Tom Loewald has been named Chief Executive Officer and a member of the company’s Board of Directors, effective September 7th.
read more
Wednesday, September 13, 2023
Eisai announced that it has established a digital business company Theoria technologies which will accelerate the development of a dementia ecosystem. Theoria technologies is a wholly owned subsidiary of Eisai.
read more
Thursday, December 14, 2023
Aptamer Group plc, renowned for pioneering Optimer® binders that drive innovation in the life sciences sector, has formalized a substantial agreement with a biotechnology company specializing in genetic medicines.
read more
Wednesday, January 25, 2017
SGS, a bio/pharmaceutical, analytical and bioanalytical contract solutions provider, has made additional investments at its laboratory in Fairfield, New Jersey, to increase services and capacity in support of extractables and leachables (E&L) testing...
read more